Brandes Investment Partners LP Has Cut Laboratory Amer Hldgs (LH) Stake by $2.84 Million as Shares Declined; Cme Group (CME) Holder Capstone Financial Advisors Has Trimmed Its Holding

CME Group Inc. (NASDAQ:CME) Logo

Brandes Investment Partners Lp decreased its stake in Laboratory Corp Amer Hldgs (LH) by 4.38% based on its latest 2019Q3 regulatory filing with the SEC. Brandes Investment Partners Lp sold 17,023 shares as the company’s stock declined 0.46% . The institutional investor held 371,688 shares of the medical specialities company at the end of 2019Q3, valued at $62.44 million, down from 388,711 at the end of the previous reported quarter. Brandes Investment Partners Lp who had been investing in Laboratory Corp Amer Hldgs for a number of months, seems to be less bullish one the $17.31 billion market cap company. The stock decreased 1.20% or $2.16 during the last trading session, reaching $178.23. About 758,241 shares traded or 29.07% up from the average. Laboratory Corporation of America Holdings (NYSE:LH) has risen 19.56% since January 16, 2019 and is uptrending. It has outperformed by 19.56% the S&P500. Some Historical LH News: 25/05/2018 – LabCorp: Will Be A Preferred National Laboratory for Substantially All of Aetna’s Members Beginning 2019; 25/04/2018 – LABCORP – 2018 ADJUSTED EPS GUIDANCE NOW INCLUDES PROJECTED NEGATIVE IMPACT FROM ASC 606 OF ABOUT $0.20 TO $0.30 PER SHARE FOR FULL YEAR 2018; 26/04/2018 – Airware Labs Announces Name Change to ltem 9 Labs Corp. and New Ticker Symbol “INLB”; 25/04/2018 – LABCORP – EFFECTIVE JANUARY 1, 2018, COMPANY ADOPTED FASB-ISSUED CONVERGED STANDARD ON REVENUE RECOGNITION (ASC 606); 25/04/2018 – LABCORP 1Q ADJ EPS $2.78, EST. $2.63; 25/04/2018 – Laboratory Corporation: Sees 2018 Revenue Growth 10.0%-12.0%; 20/03/2018 – INTERPACE DIAGNOSTICS – AGREEMENT WITH LABCORP TO FURTHER EXPAND CO’S NETWORK OF CYTOLOGY PROVIDERS IN SUPPORT OF ITS THYROID MOLECULAR BUSINESS UNIT; 07/03/2018 – Bionik Laboratories Corp. and Curexo Enter Exclusive Distribution Agreement for Sale of Robotic Rehabilitation Systems in U.S. and South Korea; 12/03/2018 – LABCORP 0 CPN CONV NOTES DUE ’21 TO ACCRUE CONTINGENT INTEREST; 25/04/2018 – LabCorp quarterly profit falls 5.4 pct

Capstone Financial Advisors Inc decreased its stake in Cme Group Inc (CME) by 7.79% based on its latest 2019Q3 regulatory filing with the SEC. Capstone Financial Advisors Inc sold 1,922 shares as the company’s stock declined 4.46% . The institutional investor held 22,735 shares of the investment bankers and brokers and service company at the end of 2019Q3, valued at $4.81 million, down from 24,657 at the end of the previous reported quarter. Capstone Financial Advisors Inc who had been investing in Cme Group Inc for a number of months, seems to be less bullish one the $73.47 billion market cap company. The stock increased 0.71% or $1.45 during the last trading session, reaching $205.01. About 1.04 million shares traded. CME Group Inc. (NASDAQ:CME) has risen 10.02% since January 16, 2019 and is uptrending. It has outperformed by 10.02% the S&P500. Some Historical CME News: 22/05/2018 – CME amends feeder cattle futures, options contract rules; 26/04/2018 – CME Group 1Q Net $598.8M; 13/03/2018 – LIVESTOCK-Higher cash prices halt CME hogs losing streak; 09/03/2018 – LIVESTOCK-CME live cattle futures snap back on bargain hunting; 18/04/2018 – CME LEAN HOG FUTURES 0#LH: SURGE MORE THAN 2 PERCENT ON FUND BUYING, HIGHER CASH AND WHOLESALE PORK PRICES -TRADE; 28/03/2018 – CME IS SAID TO OFFER ABOUT 4 BILLION POUNDS FOR NEX GROUP; 23/05/2018 – CME LIVE CATTLE BACK MONTHS 0#LC: CLIMB OVER 1 PERCENT ON TECHNICAL BUYING, POSITIONING AHEAD OF FRIDAY’S USDA MONTHLY CATTLE REPORT -TRADE; 20/03/2018 – Disrupting Business: Blockchain Technology Offers Solutions Across the Board; 03/04/2018 – CME lumber futures final vol/open int for April 2; 12/04/2018 – CME LIVE CATTLE DEFERRED CONTRACTS 0#LC: UP OVER 1 PERCENT ON SHORT-COVERING, SHARPLY HIGHER FEEDER CATTLE FUTURES -TRADE

Analysts await CME Group Inc. (NASDAQ:CME) to report earnings on February, 12 before the open. They expect $1.55 earnings per share, down 12.43% or $0.22 from last year’s $1.77 per share. CME’s profit will be $555.46M for 33.07 P/E if the $1.55 EPS becomes a reality. After $1.90 actual earnings per share reported by CME Group Inc. for the previous quarter, Wall Street now forecasts -18.42% negative EPS growth.

More notable recent CME Group Inc. (NASDAQ:CME) news were published by: Nasdaq.com which released: “February 14th Options Now Available For CME Group – Nasdaq” on January 02, 2020, also Nasdaq.com with their article: “CME Says It Will Launch Bitcoin Options in January – Nasdaq” published on November 12, 2019, Benzinga.com published: “JPMorgan Sees Institutional Interest In Options On CME Bitcoin Futures – Benzinga” on January 13, 2020. More interesting news about CME Group Inc. (NASDAQ:CME) were released by: Nasdaq.com and their article: “The Zacks Analyst Blog Highlights: Novartis, McDonald’s, Bristol-Myers Squibb, CME and UBS – Nasdaq” published on January 10, 2020 as well as Nasdaq.com‘s news article titled: “Intercontinental Exchange Names New Bakkt CEO and President – Nasdaq” with publication date: December 24, 2019.

Capstone Financial Advisors Inc, which manages about $1.12 billion and $653.91M US Long portfolio, upped its stake in Vanguard Index Fds (VTI) by 48,125 shares to 1.06M shares, valued at $159.76M in 2019Q3, according to the filing. It also increased its holding in Proshares Tr (TOLZ) by 91,011 shares in the quarter, for a total of 963,723 shares, and has risen its stake in Vanguard Charlotte Fds (BNDX).

Investors sentiment decreased to 0.97 in Q3 2019. Its down 0.02, from 0.99 in 2019Q2. It turned negative, as 33 investors sold CME shares while 270 reduced holdings. 85 funds opened positions while 208 raised stakes. 283.64 million shares or 0.30% less from 284.49 million shares in 2019Q2 were reported. Capital Counsel Ltd Liability reported 13.32% of its portfolio in CME Group Inc. (NASDAQ:CME). Capital Int Sarl has invested 2.03% of its portfolio in CME Group Inc. (NASDAQ:CME). Northern holds 0.21% or 4.13 million shares. Creative Planning holds 0.02% of its portfolio in CME Group Inc. (NASDAQ:CME) for 23,208 shares. Vident Investment Advisory Ltd Liability reported 5,017 shares or 0.09% of all its holdings. Janney Montgomery Scott Ltd Com accumulated 22,148 shares or 0.03% of the stock. Hm Payson stated it has 557 shares or 0% of all its holdings. Tiverton Asset Lc reported 0.52% in CME Group Inc. (NASDAQ:CME). Prio Wealth LP has invested 0.02% of its portfolio in CME Group Inc. (NASDAQ:CME). Evercore Wealth Management Ltd Liability Corp reported 3,083 shares or 0.02% of all its holdings. Pinnacle Assocs has 53,420 shares. Yhb Advsr Inc holds 30,793 shares or 0.99% of its portfolio. Gyroscope Management Ltd Llc invested in 2,315 shares. Moreover, Great Lakes Advsrs Lc has 0.08% invested in CME Group Inc. (NASDAQ:CME) for 18,274 shares. Menora Mivtachim, a Israel-based fund reported 388,960 shares.

Brandes Investment Partners Lp, which manages about $26.91B and $3.87 billion US Long portfolio, upped its stake in Cemex Sab De Cv (NYSE:CX) by 9.32M shares to 73.19 million shares, valued at $287.55 million in 2019Q3, according to the filing. It also increased its holding in Halliburton Co (NYSE:HAL) by 1.19 million shares in the quarter, for a total of 2.75 million shares, and has risen its stake in Edgewell Pers Care Co.

Investors sentiment increased to 1.04 in 2019 Q3. Its up 0.11, from 0.93 in 2019Q2. It increased, as 31 investors sold LH shares while 211 reduced holdings. 63 funds opened positions while 188 raised stakes. 85.85 million shares or 0.12% less from 85.95 million shares in 2019Q2 were reported. The Ontario – Canada-based Sun Life has invested 0% in Laboratory Corporation of America Holdings (NYSE:LH). Synovus Finance holds 0% or 1,240 shares in its portfolio. Quantbot Limited Partnership invested in 6,796 shares or 0.11% of the stock. New York State Teachers Retirement Sys owns 144,356 shares or 0.06% of their US portfolio. Victory invested in 0.03% or 143,981 shares. Trust Of Vermont reported 0.03% of its portfolio in Laboratory Corporation of America Holdings (NYSE:LH). First Eagle Investment Ltd Limited Liability Company accumulated 0.1% or 202,900 shares. Endurant Mngmt LP holds 4.45% or 88,983 shares in its portfolio. Madison Investment invested 0.88% of its portfolio in Laboratory Corporation of America Holdings (NYSE:LH). Guggenheim Capital Limited Com invested 0.03% of its portfolio in Laboratory Corporation of America Holdings (NYSE:LH). Davenport & Lc invested in 3,997 shares. Brown Brothers Harriman & holds 0% or 3,093 shares. 6,729 were accumulated by Asset Management Inc. Pittenger & Anderson holds 0% or 78 shares. Greenleaf Tru reported 0.06% stake.

More notable recent Laboratory Corporation of America Holdings (NYSE:LH) news were published by: Businesswire.com which released: “Enzo Biochem Responds to Series of Misleading and Inaccurate Statements from Activist Hedge Fund Harbert – Business Wire” on January 13, 2020, also Seekingalpha.com with their article: “LabCorp prices $1.05B debt offering – Seeking Alpha” published on November 19, 2019, Businesswire.com published: “Covance Launches Laboratory Data Management Functional Service Provider for Pharmaceutical and Biotechnology Customers – Business Wire” on August 29, 2019. More interesting news about Laboratory Corporation of America Holdings (NYSE:LH) were released by: Businesswire.com and their article: “LabCorp Announces Proposed Sale of Senior Notes – Business Wire” published on November 18, 2019 as well as Finance.Yahoo.com‘s news article titled: “Do You Like Laboratory Corporation of America Holdings (NYSE:LH) At This P/E Ratio? – Yahoo Finance” with publication date: January 06, 2020.

Analysts await Laboratory Corporation of America Holdings (NYSE:LH) to report earnings on February, 6. They expect $2.80 EPS, up 11.11% or $0.28 from last year’s $2.52 per share. LH’s profit will be $271.88 million for 15.91 P/E if the $2.80 EPS becomes a reality. After $2.90 actual EPS reported by Laboratory Corporation of America Holdings for the previous quarter, Wall Street now forecasts -3.45% negative EPS growth.

Laboratory Corporation of America Holdings (NYSE:LH) Institutional Positions Chart